In an effort to raise the American public’s awareness of the seriousness of deep vein thrombosis (DVT) and pulmonary embolism (PE), the CHEST Foundation has launched its OneBreath Initiative.
Made possible by funding from Janssen Pharmaceuticals Inc, OneBreath aims to improve lung and heart health by providing valuable prevention resources, raising public awareness, and encouraging healthy behaviors.
The month-long awareness effort features a series of online resources developed by the American College of Chest Physicians to help educate those who have or who are interested in learning about DVT.
“DVT can strike anyone, so it’s important to be aware of potential risk factors and warning signs,” said Lisa K. Moores, MD, FCCP. “With the help of our member physicians, experts in the treatment of pulmonary and cardiovascular conditions, as well as trusted partners, we have been able to assemble a comprehensive DVT resource based on the most advanced evidence-based clinical standards of care.”
